MARKET

EDSA

EDSA

Edesa Biotech Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.100
-0.240
-7.19%
Closed 16:00 01/24 EST
OPEN
3.300
PREV CLOSE
3.340
HIGH
3.330
LOW
3.100
VOLUME
64.02K
TURNOVER
--
52 WEEK HIGH
17.40
52 WEEK LOW
2.940
MARKET CAP
27.47M
P/E (TTM)
-3.8037
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of EDSA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

EDSA News

  • Edesa Biotech Director Van Der Velden Buys 140,625 @$3.20
  • Benzinga.01/10 19:18
  • The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering
  • Benzinga.01/07 12:57
  • Edesa Biotech down 23% on equity offering
  • seekingalpha.01/06 20:15
  • Mid-Afternoon Market Update: U.S. Markets Turn Higher; Habit Restaurants Shares Climb
  • Benzinga.01/06 19:35

More

Industry

Biotechnology & Medical Research
-2.64%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About EDSA

Edesa Biotech Inc., Stellar Biotechnologies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapeutics for dermatological and gastrointestinal indications. The Company’s lead product candidate, EB01, is a novel non-steroidal anti-inflammatory molecule (sPLA2 inhibitor) for the treatment of chronic allergic contact dermatitis. The Company has its operations in the United States and in Canada.
More

Webull offers Edesa Biotech Inc (EDSA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.